| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6099142 | Journal of Crohn's and Colitis | 2014 | 9 Pages |
Abstract
In an era of improved treatment options, the recurrence rates, but not the surgery or hospitalisation rates, have decreased for CD but not for UC. The phenotypic characteristics at diagnosis predict the risk of recurrence and hospitalisation.
Keywords
SMIEC-IBDIBDNPRRCTAZA6-Mercaptopurine6-MPazathioprineCPRMRIimmEpidemiologyImmunomodulatorsECCOHospitalisationinflammatory bowel disease unclassifiedCrohn's diseaseInflammatory bowel diseaseSmall bowel imagingMagnetic resonance imagingcomputed tomographyBiological treatmentEuropean Crohn's and Colitis OrganisationAnti-TNFRecurrence ratesRandomised clinical trialUlcerative colitiscapsule endoscopyIBDU
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Marianne K. Vester-Andersen, Ida Vind, Michelle V. Prosberg, Bo G. Bengtsson, Thomas Blixt, Pia Munkholm, Mikael Andersson, Tine Jess, Flemming Bendtsen,